News & Updates

Addressing the unmet needs and challenges in managing older AF patients

01 Apr 2022 by

A key focus in the management of atrial fibrillation (AF) in older patients is stroke prevention through oral anticoagulation. However, a significant proportion of older AF patients remain undercoagulated due to the perceived bleeding risk of oral anticoagulants (OACs). Dr Tan Vern Hsen, Senior Consultant, Department of Cardiology, Changi General Hospital, Singapore, and Dr Barbara Helen Rosario, Senior Consultant, Department of Geriatric Medicine, Changi General Hospital, Singapore, shared their respective insights into managing older AF patients for an integrated approach.

Addressing the unmet needs and challenges in managing older AF patients

01 Apr 2022

Role of apixaban in VTE management: Who, when, and how

31 Mar 2022 by

Venous thromboembolism (VTE) is associated with an increased risk of morbidity and mortality. Given the challenges posed by conventional therapies used for the treatment of VTE, Dr Lim Xiu Qi Cheryl, Associate Consultant from the Department of Haematology-Oncology at National University Cancer Institute, Singapore (NCIS), shares her insights on the role of apixaban (Eliquis, Pfizer), an oral factor Xa inhibitor, in the treatment of acute VTE and prevention of recurrent VTE.

Role of apixaban in VTE management: Who, when, and how

31 Mar 2022

Empagliflozin benefits similar between MRA users, nonusers

31 Mar 2022

In patients with heart failure (HF) and preserved ejection fraction, treatment with empagliflozin delivers comparable benefits in reducing first hospitalization for HF or cardiovascular death (primary outcome) between users and nonusers of mineralocorticoid receptor antagonists (MRA), reports a study.

Empagliflozin benefits similar between MRA users, nonusers

31 Mar 2022

MyDiagnostick delivers reliable AF screening even by nonspecialists

31 Mar 2022 by

The atrial fibrillation (AF) screening tool, MyDiagnostick, demonstrates comparable sensitivity and specificity with manual pulse checking, validated across studies performed in a multiethnic Asian population, according to a Singapore study. Of note, AF prevalence in this cohort is similar to that in other countries.

MyDiagnostick delivers reliable AF screening even by nonspecialists

31 Mar 2022

Ebbs and flows in weight influence CVD risk in T2D patients

31 Mar 2022 by

In individuals with type 2 diabetes (T2D), greater variability in adiposity indices (BMI and waist circumference [WC]) was tied to increased risk of cardiovascular disease (CVD) outcomes and death – but an intensive weight loss programme mitigated this risk, a study suggests.

Ebbs and flows in weight influence CVD risk in T2D patients

31 Mar 2022

Robotic exoskeleton helps with mobilization in patients with heart failure

31 Mar 2022 by

The use of a robotic exoskeleton is a feasible intervention to assist mobilization in patients with advanced heart failure, according to a recent study.

Robotic exoskeleton helps with mobilization in patients with heart failure

31 Mar 2022

Low-dose aspirin prevents common GI cancers in Chinese adults without ASCVD

31 Mar 2022 by

Low-dose aspirin reduces risks of some common gastrointestinal (GI) cancers, including colorectal cancer (CRC) and gastric cancer (GC), in Chinese without atherosclerotic cardiovascular disease (ASCVD), compared with paracetamol, the first population-wide study from the University of Hong Kong (HKU) has shown.

Low-dose aspirin prevents common GI cancers in Chinese adults without ASCVD

31 Mar 2022

Traumatic experiences implicated in CVD risk in women

30 Mar 2022

Interpersonal violence, such as childhood abuse and intimate partner violence, is associated with a heightened risk of developing cardiovascular disease (CVD) in women, according to a study.